ES2010775A6 - Procedimiento para la preparacion de derivados fosfatados de 4` -desmetilepipodofilotoxin glucosidos. - Google Patents

Procedimiento para la preparacion de derivados fosfatados de 4` -desmetilepipodofilotoxin glucosidos.

Info

Publication number
ES2010775A6
ES2010775A6 ES8802434A ES8802434A ES2010775A6 ES 2010775 A6 ES2010775 A6 ES 2010775A6 ES 8802434 A ES8802434 A ES 8802434A ES 8802434 A ES8802434 A ES 8802434A ES 2010775 A6 ES2010775 A6 ES 2010775A6
Authority
ES
Spain
Prior art keywords
procedure
aralkyl
compound
glucosidos
desmetilepipodofilotoxin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8802434A
Other languages
English (en)
Inventor
Mark G Saulnier
Peter D Senter
John F Kadow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ES2010775A6 publication Critical patent/ES2010775A6/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cable Accessories (AREA)
  • Mechanical Coupling Of Light Guides (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS FOSFATADOS DE 4''-DESMETILEPIPODOFILOTOXIN GLUCOSIDOS, DE FORMULA (V), DONDE R6 ES H, R1 ES ACIDO C1-10, ALQUENILO C2-10, CICLOALQUILO C5-6, 2-FURILO, 2-TIENILO, ARILO C6-10, ARALQUILO C7-14, ARALQUILO C8-14, DONDE LOS ANILLOS AROMATICOS PUEDEN ESTAR OPCIONALMENTE SUSTITUIDOS O R1 Y R6 Y EL CARBONO AL QUE ESTAN ENLAZADOS FORMAN UN GRUPO CICLOALQUILO C5-6; X ES O O S; R7 Y R8 SON H, ALQUILO C1-5, CICLOALQUILO C3-6, ARILO C6-10, ARALQUILO C7-14, OPCIONALMENTE SUSTITUIDOS. EL PROCEDIMIENTO COMPRENDE LA REACCION DE UN COMPUESTO (IX) CON P(X)CL3 PARA FORMAR UN INTERMEDIO (VIII) QUE PUEDE SER: A) HIDROLIZADO PARA FORMAR UN COMPUESTO (V) DONDE R7 Y R8 SON H; O B) COMBINADO CON AL MENOS UN EQUIVALENTE DE R7OH Y R8OH. OPCIONALMENTE EL COMPUESTO (IX) PUEDE SER PROTEGIDO EN SU GRUPO FOSFATO. LOS COMPUESTOS DE FORMULA (V) SON AGENTES ANTITUMORALES ADECUADOS PARA EL TRATAMIENTO DE DIVERSOS TIPOS DE CANCER, LEUCEMIA NO LINFOCITICA Y ENFERMEDAD DE HODKIN. ADEMAS, SUS SALES FARMACEUTICAS SON MAS SOLUBLES EN AGUA QUE LAS DE OTROS GLUCOSIDOS SIMILARES CONOCIDOS.
ES8802434A 1987-08-04 1988-08-03 Procedimiento para la preparacion de derivados fosfatados de 4` -desmetilepipodofilotoxin glucosidos. Expired ES2010775A6 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8149387A 1987-08-04 1987-08-04
US07/199,731 US4904768A (en) 1987-08-04 1988-05-27 Epipodophyllotoxin glucoside 4'-phosphate derivatives

Publications (1)

Publication Number Publication Date
ES2010775A6 true ES2010775A6 (es) 1989-12-01

Family

ID=26765636

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8802434A Expired ES2010775A6 (es) 1987-08-04 1988-08-03 Procedimiento para la preparacion de derivados fosfatados de 4` -desmetilepipodofilotoxin glucosidos.

Country Status (34)

Country Link
US (3) US4904768A (es)
JP (1) JPH0699465B2 (es)
KR (1) KR900006230B1 (es)
CN (1) CN1027169C (es)
AT (1) AT398974B (es)
BE (1) BE1002982A4 (es)
CA (1) CA1310637C (es)
CH (1) CH676716A5 (es)
CY (1) CY1625A (es)
CZ (1) CZ286893B6 (es)
DD (2) DD274423A5 (es)
DE (1) DE3826562A1 (es)
DK (2) DK169344B1 (es)
ES (1) ES2010775A6 (es)
FI (1) FI87790C (es)
FR (1) FR2622193B1 (es)
GB (1) GB2207674B (es)
GR (1) GR1000490B (es)
HK (1) HK6392A (es)
HU (3) HU208147B (es)
IE (1) IE61040B1 (es)
IL (1) IL87290A (es)
IT (1) IT1226825B (es)
LU (2) LU87290A1 (es)
MX (1) MX173843B (es)
MY (1) MY104321A (es)
NL (2) NL192683C (es)
NO (4) NO170284C (es)
NZ (1) NZ225615A (es)
PT (1) PT88186B (es)
SE (1) SE502214C2 (es)
SG (1) SG101291G (es)
SK (1) SK541288A3 (es)
YU (3) YU143688A (es)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5191071A (en) * 1987-08-21 1993-03-02 Novo Nordisk A/S Monoesters of glycosides and a process for enzymatic preparation thereof
US4965348A (en) * 1989-05-19 1990-10-23 Bristol-Myers Company Dimeric epipodophyllotoxin glucoside derivatives
US5036055A (en) * 1989-06-07 1991-07-30 Bristol-Myers Company Acylated derivatives of etoposide
US5066645A (en) * 1989-09-01 1991-11-19 Bristol-Myers Company Epipodophyllotoxin altroside derivatives
US6610299B1 (en) 1989-10-19 2003-08-26 Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
US7241595B2 (en) 1989-10-20 2007-07-10 Sanofi-Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
US6475486B1 (en) 1990-10-18 2002-11-05 Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
US5552154A (en) 1989-11-06 1996-09-03 The Stehlin Foundation For Cancer Research Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof
US5034380A (en) * 1989-11-20 1991-07-23 Bristol-Myers Squibb Company Alkoxymethylidene epipodophyllotoxin glucosides
US5081234A (en) * 1990-04-30 1992-01-14 Bristol-Myers Squibb Co. 4'-demethylepipodophyllotoxin glycosides
US4997931A (en) * 1990-06-11 1991-03-05 Bristol-Myers Squibb Company Epipodophyllotoxin glycosides
TW260671B (es) * 1991-04-29 1995-10-21 Bristol Myers Squibb Co
IT1250692B (it) * 1991-07-23 1995-04-21 Procedimento per la preparazione di demetilepipodofillotossina- beta-d-glucosidi.
US5648474A (en) * 1991-10-08 1997-07-15 Bristol-Myers Squibb Crystalline etoposide 4'-phosphate diethanolate
JPH07632B2 (ja) * 1991-12-23 1995-01-11 ブリストル−マイヤーズ スクイブ カンパニー エトポシド４’−ホスフェート二ナトリウム塩の安定な六水和物
US6080751A (en) * 1992-01-14 2000-06-27 The Stehlin Foundation For Cancer Research Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof
JP3061476B2 (ja) * 1992-04-24 2000-07-10 日本化薬株式会社 エトポシド燐酸エステルの製造法
US5459248A (en) * 1993-11-04 1995-10-17 Bristol-Myers Squibb Company Process of preparing etoposide phosphate and etoposide
FR2725990B1 (fr) * 1994-10-21 1997-01-10 Pf Medicament Derives hydrosolubles d'epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux
US5942386A (en) * 1995-06-07 1999-08-24 Thomas Jefferson University Anti-fungal agents and methods of identifying and using the same
ATE268187T1 (de) 1996-04-01 2004-06-15 Epix Medical Inc Bioaktivierte diagnostische bilderzeugungskontrastmittel
US6207673B1 (en) 1997-03-12 2001-03-27 The University Of North Carolina At Chapel Hill Covalent conjugates of topoisomerase I and topoisomerase II inhibitors
WO1999032499A1 (en) * 1997-12-23 1999-07-01 Korea Research Institute Of Chemical Technology 4'-O-DEMETHYL-EPIPODOPHYLLOTOXIN-β-D-GLUCOSIDE ACETAL DERIVATIVES
HK1049787B (en) 1999-10-01 2014-07-25 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6624317B1 (en) 2000-09-25 2003-09-23 The University Of North Carolina At Chapel Hill Taxoid conjugates as antimitotic and antitumor agents
US6506739B1 (en) 2001-05-01 2003-01-14 Telik, Inc. Bis-(N,N'-bis-(2-haloethyl)amino)phosphoramidates as antitumor agents
EP1438319A1 (en) * 2001-10-26 2004-07-21 Centre National De La Recherche Scientifique (Cnrs) Derivatives of etoposide and analogs, and pharmaceutical compositions containing them
SI2269656T1 (sl) 2002-07-15 2014-11-28 Board Of Regents, The University Of Texas System Izbrana protitelesa, ki se veĹľejo na aminofosfolipide, in njihova uporaba v zdravljanju raka
JP4903036B2 (ja) * 2003-01-06 2012-03-21 アンジオケム・インコーポレーテッド 血液脳関門を通過する担体としてのアプロチニンおよび類似体
CN100334090C (zh) * 2005-02-02 2007-08-29 南京医科大学 吡啶类鬼臼毒素化合物及其制备方法和在制备杀虫剂中的应用
US20090016959A1 (en) * 2005-02-18 2009-01-15 Richard Beliveau Delivery of antibodies to the central nervous system
EP2360258B1 (en) * 2005-02-18 2014-10-08 Angiochem Inc. Aprotinin polypeptides for transporting a compound across the blood-brain barrier
DK2233156T3 (da) 2005-07-15 2013-08-05 Angiochem Inc Anvendelse af aprotininpolypeptider som bærere i farmaceutiske konjugater
CN100410266C (zh) * 2006-01-11 2008-08-13 重庆华邦制药股份有限公司 鬼臼毒素磷酸酯衍生物的合成方法
JO2660B1 (en) 2006-01-20 2012-06-17 نوفارتيس ايه جي Pi-3 inhibitors and methods of use
PE20070978A1 (es) * 2006-02-14 2007-11-15 Novartis Ag COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks)
TW200808739A (en) * 2006-04-06 2008-02-16 Novartis Vaccines & Diagnostic Quinazolines for PDK1 inhibition
GB0625283D0 (en) * 2006-12-19 2007-01-24 Cyclacel Ltd Combination
US9365634B2 (en) * 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
WO2009036106A1 (en) * 2007-09-13 2009-03-19 Bristol-Myers Squibb Company Cytotoxic xanthone compounds
JP5809415B2 (ja) 2007-11-09 2015-11-10 ペレグリン ファーマシューティカルズ，インコーポレーテッド 抗ｖｅｇｆ抗体の組成物および方法
PE20091523A1 (es) 2007-12-20 2009-10-29 Novartis Ag Derivados de tiazol como inhibidores de la enzima fosfatidilinositol 3-cinasa (pi3k)
AU2009238187B2 (en) * 2008-04-18 2014-03-06 Angiochem Inc. Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use
EP2346896A4 (en) 2008-10-15 2014-06-25 Angiochem Inc ETOPOSID AND DOXORUBICIN CONJUGATES FOR ACTIVITY EXTRACTION
US8921314B2 (en) 2008-10-15 2014-12-30 Angiochem, Inc. Conjugates of GLP-1 agonists and uses thereof
JP5759379B2 (ja) * 2008-12-05 2015-08-05 アンジオケム インコーポレーテッド ニューロテンシンまたはニューロテンシンアナログおよびその使用
WO2010069074A1 (en) 2008-12-17 2010-06-24 Universite Du Quebec A Montreal Membrane type-1 matrix metalloprotein inhibitors and uses thereof
ES2729261T3 (es) 2009-04-20 2019-10-31 Angiochem Inc Tratamiento del cáncer de ovario utilizando un agente anticancerígeno conjugado con un análogo de Angiopep-2
CN102596993A (zh) 2009-07-02 2012-07-18 安吉奥开米公司 多聚体肽结合物以及其应用
US8293753B2 (en) 2009-07-02 2012-10-23 Novartis Ag Substituted 2-carboxamide cycloamino ureas
EP2539337A1 (en) 2010-02-22 2013-01-02 F. Hoffmann-La Roche AG Pyrido[3,2-d]pyrimidine pi3k delta inhibitor compounds and methods of use
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
AR082418A1 (es) 2010-08-02 2012-12-05 Novartis Ag Formas cristalinas de 1-(4-metil-5-[2-(2,2,2-trifluoro-1,1-dimetil-etil)-piridin-4-il]-tiazol-2-il)-amida de 2-amida del acido (s)-pirrolidin-1,2-dicarboxilico
AU2012213080B2 (en) 2011-01-31 2014-03-27 Novartis Ag Novel heterocyclic derivatives
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
KR20140090218A (ko) 2011-10-28 2014-07-16 노파르티스 아게 신규 퓨린 유도체 및 질환의 치료에서의 그의 용도
JP2015500833A (ja) * 2011-12-09 2015-01-08 デメレックス， インコーポレイテッド ノルイボガインのリン酸エステル
WO2013173283A1 (en) 2012-05-16 2013-11-21 Novartis Ag Dosage regimen for a pi-3 kinase inhibitor
JP2016508979A (ja) 2012-12-20 2016-03-24 デメレックス， インコーポレイテッド 置換ノルイボガイン
CA2930359C (en) 2013-12-06 2022-03-01 Novartis Ag Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitor
JP6823055B2 (ja) 2015-06-15 2021-01-27 アンジオケム インコーポレーテッド 軟髄膜癌腫症の治療方法
RU2018119085A (ru) 2015-11-02 2019-12-04 Новартис Аг Схема введения ингибитора фосфатидилинозитол-3-киназы
WO2018060833A1 (en) 2016-09-27 2018-04-05 Novartis Ag Dosage regimen for alpha-isoform selective phosphatidylinositol 3-kinase inhibitor alpelisib
KR102378151B1 (ko) 2020-05-11 2022-03-24 주식회사 제이앤씨사이언스 베타-아포피크로포도필린의 신규한 유도체

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1171314A (fr) * 1955-05-13 1959-01-23 Sandoz Ag Produits de condensation de glucosides avec des composés carbonyliques et leur préparation
NL6613143A (es) * 1965-09-21 1967-03-22
CH464957A (de) * 1965-12-14 1968-11-15 Sandoz Ag Verfahren zur Herstellung eines neuen Glucosids
CH544752A (de) * 1966-12-13 1974-01-15 Sandoz Ag Verfahren zur Herstellung neuer Glucoside
CH514578A (de) * 1968-02-27 1971-10-31 Sandoz Ag Verfahren zur Herstellung von Glucosiden
CH543502A (de) * 1970-11-20 1973-10-31 Sandoz Ag Verfahren zur Herstellung neuer Glucoside
GB1395820A (en) * 1971-06-05 1975-05-29 Villax I Preparation of 21-inorganic esters of corticosteroids and salts thereof
CH589668A5 (en) * 1973-06-07 1977-07-15 Sandoz Ag Cytostatic (4')-demethyl substd. epipodophyllotoxin - prepd. from the corresp. glucopyranoside with (3)-thiophene-carboxaldehyde
FR2397425A1 (fr) * 1977-07-11 1979-02-09 Rhone Poulenc Ind Nouveaux derives de la daunorubicine, leur preparation et les compositions qui les contiennent
EP0111058B1 (en) * 1982-11-26 1987-11-04 Nippon Kayaku Kabushiki Kaisha Process for producing 4'-demethyl-epipodophyllotoxin-beta-d-ethylidene-glucoside and acyl-derivative thereof
US4567253A (en) * 1984-02-03 1986-01-28 Tony Durst 2-Substituted derivatives of podophyllotoxin and etoposide
JPS60208910A (ja) * 1984-03-31 1985-10-21 Green Cross Corp:The 水難溶性薬物・リン脂質複合体の製造方法
JPS60246393A (ja) * 1984-05-22 1985-12-06 Nippon Kayaku Co Ltd エトポシドの新規製造法
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
IL77334A (en) * 1985-12-16 1991-04-15 Univ Bar Ilan Synthesis of 9-epipodophyllotoxin glucoside derivatives and some novel intermediates therefor
US4916217A (en) * 1987-01-08 1990-04-10 Bristol-Myers Company Phosphorus containing derivatives of epipodophyllotoxin
JPS63192793A (ja) * 1987-02-06 1988-08-10 Nippon Kayaku Co Ltd ４′−デメチル−エピポドフイロトキシン誘導体の新規エステル
US4874851A (en) * 1987-07-01 1989-10-17 Bristol-Meyers Company 3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivatives

Also Published As

Publication number Publication date
SE502214C2 (sv) 1995-09-18
CN1027169C (zh) 1994-12-28
DK11992A (da) 1992-01-31
MX173843B (es) 1994-03-30
FR2622193A1 (fr) 1989-04-28
PT88186A (pt) 1989-06-30
PT88186B (pt) 1995-07-03
NO920665D0 (no) 1992-02-20
NL192683C (nl) 1997-12-02
CA1310637C (en) 1992-11-24
CH676716A5 (es) 1991-02-28
GB2207674B (en) 1991-09-11
NO883299D0 (no) 1988-07-26
FI87790C (fi) 1993-02-25
GB2207674A (en) 1989-02-08
NO172440C (no) 1993-07-21
IT8821535A0 (it) 1988-07-28
YU143688A (en) 1990-04-30
DK434088D0 (da) 1988-08-03
US4904768A (en) 1990-02-27
USRE35524E (en) 1997-06-03
NO1998002I1 (no) 1998-01-14
FI883596A7 (fi) 1989-02-05
HU202547B (en) 1991-03-28
DK434088A (da) 1989-02-05
NO920277L (no) 1989-02-24
DK11992D0 (da) 1992-01-31
DE3826562A1 (de) 1989-02-16
ATA195588A (de) 1994-07-15
AU610619B2 (en) 1991-05-23
DD274423A5 (de) 1989-12-20
MX9202851A (es) 1992-06-30
AU2030688A (en) 1989-06-08
HK6392A (en) 1992-01-17
NL192683B (es) 1997-08-01
HUT47303A (en) 1989-02-28
CZ541288A3 (cs) 1999-12-15
FI883596A0 (fi) 1988-08-01
NO170284C (no) 1992-09-30
DE3826562C2 (es) 1993-04-08
NL8801934A (nl) 1989-03-01
DK169344B1 (da) 1994-10-10
LU90138I2 (fr) 1997-11-26
MY104321A (en) 1994-03-31
CN1061225A (zh) 1992-05-20
SG101291G (en) 1992-01-17
GR1000490B (el) 1992-07-30
AT398974B (de) 1995-02-27
HU905862D0 (en) 1991-03-28
IE61040B1 (en) 1994-09-07
HU211960A9 (en) 1996-01-29
IL87290A0 (en) 1989-01-31
NL970042I2 (es) 2005-06-01
DD299067A5 (de) 1992-03-26
NO920277D0 (no) 1992-01-22
CZ286893B6 (cs) 2000-07-12
CY1625A (en) 1992-07-10
LU87290A1 (fr) 1990-02-07
FR2622193B1 (fr) 1993-12-17
GR880100512A (en) 1989-05-25
JPH0699465B2 (ja) 1994-12-07
JPH01100188A (ja) 1989-04-18
IL87290A (en) 1993-01-31
IT1226825B (it) 1991-02-19
SK279325B6 (sk) 1998-10-07
GB8818462D0 (en) 1988-09-07
NL970042I1 (nl) 1998-03-02
NO920665L (no) 1989-02-24
NO172440B (no) 1993-04-13
HU208147B (en) 1993-08-30
YU10490A (en) 1990-06-30
NO170284B (no) 1992-06-22
FI87790B (fi) 1992-11-13
KR890003790A (ko) 1989-04-18
KR900006230B1 (ko) 1990-08-27
SE8802815D0 (sv) 1988-08-03
US5041424A (en) 1991-08-20
BE1002982A4 (fr) 1991-10-15
IE882378L (en) 1989-02-04
YU10390A (en) 1990-06-30
SK541288A3 (en) 1998-10-07
NO883299L (no) 1989-02-24
NZ225615A (en) 1991-06-25
SE8802815L (sv) 1989-02-05

Similar Documents

Publication Publication Date Title
ES2010775A6 (es) Procedimiento para la preparacion de derivados fosfatados de 4` -desmetilepipodofilotoxin glucosidos.
ES8300716A1 (es) Procedimiento para preparar derivados de 2-amino-4-hidroxi- quinazolina
AR241222A1 (es) Procedimiento para elaborar nuevos acidos 3-amino- (1) benzazepin-2-alcanoicos y sus sales.
DK0447285T3 (da) Nephtalenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
ES2032749T3 (es) Acidos oxoftalazinil-aceticos heterociclicos.
ES8800911A1 (es) Procedimiento para preparar derivados de quinazolina
ES521655A0 (es) Procedimiento para la preparacion de aminoacidos ciclicos o esteres de los mismos.
PE49696A1 (es) Compuesto carbociclico
SE8603099D0 (sv) Distamycin derivatives and process for their preparation
SE8604950L (sv) Demensforbettrande och terapeutiska medel
ES8505518A1 (es) Procedimiento para preparar derivados de aminoacidos
ES2081817T3 (es) Polipeptido con secuencias principales repetidas que se fijan en la celula.
ES2001094A6 (es) Un procedimiento para la preparacion de un derivado de guanina
DE68926981D1 (de) Cephemverbindungen und Verfahren zu ihrer Herstellung
ES8303427A1 (es) "un procedimiento para preparar compuestos de cefem".
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
ES2012736A6 (es) Procedimiento para la preparacion de derivados triciclicos de 3-oxopropanonitrilo.
NO167286C (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzotiazepin-derivater.
FR2413358A1 (fr) Nouveaux derives de 2-aminomethylphenol, utiles notamment comme agents anti-inflammatoires, et leur procede de preparation
ES8605823A1 (es) Procedimiento de obtencion de nuevos derivados gonadoliberinos y de sus sales de adicion formadas con acidos terapeuticamente utilizables y complejos de los mismos
DE3676378D1 (de) Isoxazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutischen praeparate.
PE25195A1 (es) Sintesis de l-aspartil-d-aminoalcanoil-(s)-o-alquilbencil amida utilizada como endulzante artificial
ES8201525A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1,1'-bifenil-2-il-alquilamina
DK614989A (da) Indolderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem
DE69011748D1 (de) Biphenyl-Derivate, Verfahren zu deren Herstellung und deren Zwischenprodukte.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20080804